Chemomab Therapeutics Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.70-2.88-2.80-2.60
Price/Sales ratio
N/A0.460.31N/A
Earnings per Share (EPS)
$-0.37$-0.34$-0.35$-0.38

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.24-9.91-0.79-7.91-1.41-8.65-5.70-1.31-0.24-0.65-4.66
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
18.3414.25-12.8011.132.584.751.161.000.350.493.67
Price/Cash Flow ratio
-5.33-12.60-0.91-7.67-2.33-9.79-5.78-1.78-0.25-0.88-5.00
Price/Free Cash Flow ratio
-5.26-12.35-0.91-7.56-2.32-9.72-5.67-1.78-0.25-0.88-4.94
Price/Earnings Growth ratio
N/A0.21-0.000.080.050.100.09-0.010.010.000.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-2.96%-3.40%-2.26%N/A0.35%-0.61%1.89%N/A1.89%-1.13%
Return on Assets
-213.36%-83.77%-469.86%-108.12%-137.74%-47.53%-19.50%-64.19%-109.34%-64.19%-122.93%
Return On Equity
-349.69%-143.72%1610.18%-140.72%-182.51%-54.89%-20.42%-76.32%-142.50%-58.22%-161.62%
Return on Capital Employed
-326.74%-140.69%1542.20%-130.15%-125.43%-53.51%-20.09%-78.57%-147.05%-78.57%-127.79%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A2.36N/AN/AN/A6.181.18
Quick Ratio
2.322.060.584.004.419.4941.586.184.315.974.21
Cash ratio
1.651.930.532.734.268.875.542.001.922.006.56
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A0.00N/A-425.83-0.70-2.99K-509.60KN/AN/AN/A-213.26
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
8.19K956.821.14K2.18K32.36424.3114.33K10.66K2.81KN/A228.34
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.01N/AN/AN/AN/A0.150.08
Debt Equity Ratio
N/AN/AN/AN/A0.02N/AN/AN/AN/A0.180.10
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
N/AN/AN/AN/A0.02N/AN/AN/AN/A0.000.01
Interest Coverage Ratio
N/AN/AN/AN/AN/A-1.82KN/AN/AN/A-80.83-913.58
Cash Flow to Debt Ratio
N/AN/AN/AN/A-42.22N/AN/AN/AN/A-95.18-21.11
Company Equity Multiplier
1.631.71-3.421.301.321.151.041.181.301.181.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.021.001.011.001.001.011.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/A-42.22N/AN/AN/AN/A-95.18-21.11
Short Term Coverage Ratio
N/AN/AN/AN/A-42.22N/AN/AN/AN/A-165.60-21.11
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A